Neuroendocrine tumors and rare gastrointestinal malignancies represent a diverse and complex group of diseases with variable clinical behavior. Improved awareness, advanced imaging, and biomarker development have led to increased detection. Accurate classification and staging are essential for appropriate management. Treatment often requires individualized strategies involving surgery, endoscopic therapy, systemic treatment, and targeted approaches. Long-term surveillance is critical due to the risk of recurrence and progression. This topic addresses diagnostic challenges, evolving therapeutic options, and multidisciplinary management of rare GI cancers.
Title : Gastroenterology viewed through a glass darkly an IDI perspective
Gilles R G Monif, University of Florida and Infectious Diseases Incorporated, United States
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena Hospital, Italy
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, Department of Public Health of Romagna, Italy
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil